XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net income $ 75,035 $ 46,089
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 21,328 22,088
Amortization of right-of-use lease assets 8,054 8,860
Stock-based compensation 41,504 45,942
Gain on investment 0 (9,766)
Other non-cash items, net (617) (273)
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Accounts receivable 105,512 57,316
Accounts payable and accrued expenses 7,680 12,959
Accrued compensation and benefits (17,530) 2,853
Deferred revenue (19,635) (13,696)
Accrued income taxes (16,836) (8,328)
Other current assets and prepaid expenses 2,956 (13,474)
Operating lease liabilities 7,895 (2,343)
Other noncurrent assets and liabilities (34,425) (10,491)
Net cash provided by operating activities 180,921 137,736
Cash flows from investing activities:    
Additions to property and equipment (9,180) (3,362)
Purchase of intangible assets 0 (450)
Settlement of net investment hedges (10,795) 6,473
Divestitures of businesses and assets, net (154) 0
Net cash (used in) provided by investing activities (20,129) 2,661
Cash flows from financing activities:    
Repurchases of common stock 0 (119,739)
Payments of withholding taxes in connection with stock-based awards (52,423) (49,165)
Payments of principal for financing leases (217) (239)
Credit facility origination costs (1,350) 0
Net cash used in financing activities (53,990) (169,143)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 8,616 (1,661)
Net change in cash, cash equivalents, and restricted cash 115,418 (30,407)
Cash, cash equivalents, and restricted cash, beginning of period 272,888 327,046
Cash, cash equivalents, and restricted cash, end of period 388,306 296,639
Supplemental disclosure of non-cash financing activities:    
Withholding taxes in connection with stock-based awards, accrued 452 0
Repurchases of common stock, accrued $ 0 $ (5,260)